Factor XI inhibitor–based anticoagulation strategies gain ground
November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
Higher death rate seen in cancer patients with nosocomial COVID-19
July 30, 2020
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
Doctors push back on treating COVID-19 as HAPE
April 21, 2020
The pathophysiological mechanism of HAPE is a “fundamentally different phenomenon” than what is seen in COVID-19–related ARDS, experts noted in a recent commentary.
Is protocol-driven COVID-19 respiratory therapy doing more harm than good?
April 6, 2020
“This is a kind of disease in which you don’t have to follow the protocol – you have to follow the physiology. Unfortunately, many, many doctors around the world cannot think outside the protocol,” said Dr. Luciano Gattinoni.
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
March 24, 2020
But a WHO expert said the organization needs to look into whether anosmia is an early sign and symptom.
COVID-19 in China: Children have less severe disease, but are vulnerable
March 19, 2020
The findings of this case review underscore the possibility that children “may play a major role in community-based viral transmission” of novel coronavirus 2019.
Wuhan case review: COVID-19 characteristics differ in children vs. adults
March 13, 2020
“Early chest CT screening and timely follow-up, combined with corresponding pathogen detection, is a feasible clinical protocol in children.”
The 2019 novel coronavirus: Case review IDs clinical characteristics
February 5, 2020
A review of coronavirus pneumonia cases in Wuhan, China, suggests older men and those with comormid conditions are most likely to be affected by the 2019-nCoV.
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
Large population-based study underscores link between gout, CVD event risk
November 23, 2019
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.